COMPOUNDS THAT TARGET MYC microRNA RESPONSIVE ELEMENTS FOR THE TREATMENT OF MYC-ASSOCIATED CANCER

Pier Paolo Pandolfi (Inventor), Assaf C Bester (Inventor), Yvonne Tay (Inventor)

Research output: Patent

Abstract

Novel mIR-330 agents and their methods of use are provided. Methods of treating MYC-associated cancers are provided.

This output contributes to the following UN Sustainable Development Goals (SDGs)

@misc{f603f52abab1498c85a2a71c6a650b68,

title = "COMPOUNDS THAT TARGET MYC microRNA RESPONSIVE ELEMENTS FOR THE TREATMENT OF MYC-ASSOCIATED CANCER",

abstract = "Novel mIR-330 agents and their methods of use are provided. Methods of treating MYC-associated cancers are provided.",

author = "Pandolfi, {Pier Paolo} and Bester, {Assaf C} and Yvonne Tay",

year = "2018",

month = jul,

day = "12",

language = "American English",

type = "Patent",

note = "US2018195067; C12N 15/ 113 A I",

}

TY - PAT

T1 - COMPOUNDS THAT TARGET MYC microRNA RESPONSIVE ELEMENTS FOR THE TREATMENT OF MYC-ASSOCIATED CANCER

AU - Pandolfi, Pier Paolo

AU - Bester, Assaf C

AU - Tay, Yvonne

PY - 2018/7/12

Y1 - 2018/7/12

N2 - Novel mIR-330 agents and their methods of use are provided. Methods of treating MYC-associated cancers are provided.

AB - Novel mIR-330 agents and their methods of use are provided. Methods of treating MYC-associated cancers are provided.

M3 - Patent

M1 - US2018195067

ER -